Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels Source: Eur Respir J 2006; 27: 121-127 Year: 2006
Correlation between severity of obstructive sleep apnea (Osa) and serum total cholesterol: Hdl cholesterol (Tc:Hdl) ratio Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema Source: Eur Respir J 2014; 43: 1003-1017 Year: 2014
Low-density lipoprotein cholesterol is associated with inspiratory capacity to total lung capacity ratio in AECOPD patients Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Decreased levels of high-density lipoprotein cholesterol in patients with sarcoidosis and relationship with disease activity Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004
Effects of CETP and APOE polymorphisms on lipoprotein levels in patients with obstructive sleep apnea Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012
LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015
Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea Source: Eur Respir J 2014; 43: 1097-1105 Year: 2014
Elevated serum levels of oxidized low-density lipoprotein in COPD patients Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
C-reactive protein (CRP) levels in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 1046-1048 Year: 2012
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004